In the liver, EDIL3 is elevated in HCC and higher expression is a prognostic factor for poor overall survival, possibly due to the overexpression of EDIL3 triggering TGF-β signaling that further promotes angiogenesis and invasion [59,60,61]. This evidence concerns the gene EDIL3 and hepatocellular carcinoma.